Gut-specific inhibition of PPARα as a novel approach of NAFLD treatment
Hepatology
.
2023 Jan 1;77(1):15-17.
doi: 10.1002/hep.32592.
Epub 2022 Jun 17.
Authors
Lanjing Zhang
1
2
3
,
Grace L Guo
4
5
Affiliations
1
Department of Pathology , Princeton Medical Center , Plainsboro , New Jersey , USA.
2
Department of Biological Sciences , Rutgers University , Newark , New Jersey , USA.
3
Department of Chemical Biology , Ernst Mario School of Pharmacy, Rutgers University , Piscataway , New Jersey , USA.
4
Department of Pharmacology and Toxicology , Ernst Mario School of Pharmacy, Rutgers University , Piscataway , New Jersey , USA.
5
Research and Development Service, Veterans Health Administration , New Jersey Health Care System , East Orange , New Jersey , USA.
PMID:
35633082
DOI:
10.1002/hep.32592
No abstract available
Publication types
Editorial
Comment
MeSH terms
Hepatocytes
Humans
Liver
Non-alcoholic Fatty Liver Disease* / drug therapy
PPAR alpha
Substances
PPAR alpha